loadpatents
name:-0.018301963806152
name:-0.011565923690796
name:-0.00050497055053711
Nodwell; Matthew B. Patent Filings

Nodwell; Matthew B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nodwell; Matthew B..The latest application filed is for "cross-linked glycopeptide-cephalosporin antibiotics".

Company Profile
0.8.15
  • Nodwell; Matthew B. - Vancouver CA
  • Nodwell; Matthew B. - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cephalosporin compounds
Grant 7,871,997 - Fatheree , et al. January 18, 2
2011-01-18
Cross-linked Glycopeptide-cephalosporin Antibiotics
App 20100197569 - Fatheree; Paul R. ;   et al.
2010-08-05
Cross-linked glycopeptide-cephalosporin antibiotics
Grant 7,612,037 - Fatheree , et al. November 3, 2
2009-11-03
Aryl aniline .beta..sub.2 adrenergic receptor agonists
Grant 7,582,765 - Moran , et al. September 1, 2
2009-09-01
Cross-linked glycopeptide-cephalosporin antibiotics
App 20080194465 - Fatheree; Paul R. ;   et al.
2008-08-14
Cross-linked glycopeptide-cephalosporin antibiotics
App 20080194464 - Fatheree; Paul R. ;   et al.
2008-08-14
Cross-linked glycopeptide-cephalosporin antibiotics
App 20080108558 - Fatheree; Paul R. ;   et al.
2008-05-08
Cross-linked glycopeptide - cephalosporin antibiotics
App 20080103299 - Fatheree; Paul R. ;   et al.
2008-05-01
Cross-linked glycopeptide--cephalosporin antibiotics
Grant 7,341,993 - Fatheree , et al. March 11, 2
2008-03-11
Cross-linked glycopeptide-cephalosporin antibiotics
App 20080045721 - Fatheree; Paul R. ;   et al.
2008-02-21
Cross-linked glycopeptide-cephalosporin antibiotics
Grant 7,332,471 - Fatheree , et al. February 19, 2
2008-02-19
Cross-lined glycopeptide-cephalosporin antibiotics
App 20080039374 - Fatheree; Paul R. ;   et al.
2008-02-14
Cross-linked glycopeptide-cephalosporin antibiotics
App 20080039611 - Fatheree; Paul R. ;   et al.
2008-02-14
Aryl aniline beta2 adrenergic receptor agonists
App 20070225329 - Moran; Edmund J. ;   et al.
2007-09-27
Cross-linked glycopeptide-cephalosporin antibiotics
Grant 7,067,481 - Fatheree , et al. June 27, 2
2006-06-27
Cross-linked glycopeptide-cephalosporin antibiotics
App 20060128612 - Fatheree; Paul R. ;   et al.
2006-06-15
Cross-linked glycopeptide-cephalosporin antibiotics
Grant 6,974,797 - Fatheree , et al. December 13, 2
2005-12-13
Cross-linked glycopeptide - cephalosporin antibiotics
App 20050239691 - Fatheree, Paul R. ;   et al.
2005-10-27
Cross-linked glycopeptide-cephalosporin antibiotics
App 20040266666 - Fatheree, Paul R. ;   et al.
2004-12-30
Aryl aniline beta2 adrenergic receptor agonists
App 20040063755 - Moran, Edmund J. ;   et al.
2004-04-01
Aryl aniline .beta.2 adrenergic receptor agonists
Grant 6,670,376 - Moran , et al. December 30, 2
2003-12-30
Aryl aniline beta2 adrenergic receptor agonists
App 20030229058 - Moran, Edmund J. ;   et al.
2003-12-11
Cross-linked glycopeptide-cephalosporin antibiotics
App 20030130173 - Fatheree, Paul R. ;   et al.
2003-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed